扩散性肝动脉扩张:早期肝硬化的一个不常见的表现
Van Trung Hoang1, Hoang Anh Thi Van1, The Huan Hoang1
1Department of Radiology, Thien Hanh Hospital, 17 Nguyen Chi Thanh Street, Dak Lak 63000, Vietnam.
Oxford medical case reports
|November 28, 2025
概括
这项案例研究突出了65岁的慢性肝病患者的扩散性肝动脉扩张. 早期诊断和治疗可以防止肝硬化进展,强调精心分化血管异常.
科学领域:
- 血管医学 血管医学
- 肝病学 肝病学是一种肝病学.
- 诊断成像 诊断成像 诊断成像
背景情况:
- 肝动脉扩张可能与慢性肝病有关.
- 将其与其他血管异常区分开来,对于适当的管理至关重要.
- 门高血压的缺失可能会使诊断复杂化.
研究的目的:
- 在患有慢性肝病的患者中呈现扩散性肝动脉扩张的情况.
- 讨论这种情况的诊断和治疗考虑.
- 强调区分肝动脉扩张与其他血管异常的重要性.
主要方法:
- 一个65岁的男性患者的病例报告.
- 审查实验室测试和成像研究.
- 临床相关性和诊断方面的考虑.
主要成果:
- 患者呈现了扩散性肝动脉扩张和慢性肝病的迹象.
- 已记录了扩张血管的具体测量结果.
- 使用肝脏保护剂的治疗可以预防肝硬化进展.
结论:
- 肝动脉扩张需要仔细区分其他血管异常,特别是没有门脉高血压.
- 高分辨率成像和临床相关性对于准确诊断至关重要.
- 及时治疗可以预防肝病的进展.
相关概念视频
Diseases of the Liver and Gallbladder
1.8K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.8K
Esophageal Varices-I: Introduction
1.1K
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
1.1K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
203
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
203
Esophageal Varices-II: Clinical Features and Management
343
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
343
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
169
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
169
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
326
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
326


